We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Iron Fortified Beverages and Application in Women Predisposed to Anemia (FeDrink)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01135576
Recruitment Status : Completed
First Posted : June 3, 2010
Last Update Posted : December 24, 2012
Information provided by (Responsible Party):

Study Description
Brief Summary:
  • The objective of the study is to know if consumption of an iron fortified fruit juice containing micronized iron pyrophosphate, is useful to increase iron status in women predisposed to iron deficiency anemia.
  • A secondary objective is to know if consumption of this iron fortified fruit juice modifies bone remodelling.

Condition or disease Intervention/treatment
Iron-deficiency Anemia Dietary Supplement: non-fortified fruit juices consumed as part of the usual diet Dietary Supplement: Iron fortified fruit juice

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 122 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Study Start Date : November 2008
Primary Completion Date : January 2009
Study Completion Date : May 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anemia Iron
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Placebo Comparator: Placebo juices
Consumption of non-iron fortified fruit juices as part of the usual diet
Dietary Supplement: non-fortified fruit juices consumed as part of the usual diet
Experimental: Iron fortified fruit juices
Consumption of iron fortified fruit juices as part of the usual diet
Dietary Supplement: Iron fortified fruit juice
Consumption of micronized iron pyrophosphate supplemented fruit juices as part of the usual diet

Outcome Measures

Primary Outcome Measures :
  1. Serum Ferritin [ Time Frame: monitored during 16 weeks ]

Secondary Outcome Measures :
  1. Serum transferrin [ Time Frame: monitored during 16 weeks ]
  2. Hemoglobin [ Time Frame: monitored during 16 weeks ]
  3. serum iron [ Time Frame: monitored during 16 weeks ]
  4. transferrin saturation [ Time Frame: monitored during 16 weeks ]
  5. soluble transferrin receptor [ Time Frame: monitored during 16 weeks ]
  6. zinc protoporphyrin [ Time Frame: monitored during 16 weeks ]
  7. Total red blood cells [ Time Frame: monitored during 16 weeks ]
  8. Hematocrit [ Time Frame: monitored during 16 weeks ]
  9. Mean corpuscular volume [ Time Frame: monitored during 16 weeks ]
  10. Red blood cell distribution width [ Time Frame: monitored during 16 weeks ]
  11. 25-hydroxycholecalciferol [ Time Frame: monitored during 16 weeks ]
  12. alkaline phosphatase bone-isoenzyme (ALP) [ Time Frame: monitored during 16 weeks ]
  13. serum cross-linked N-telopeptide of type I collagen (NTx) [ Time Frame: monitored during 16 weeks ]
  14. Total cholesterol [ Time Frame: monitored during 16 weeks ]
  15. HDL-cholesterol [ Time Frame: monitored during 16 weeks ]
  16. LDL-cholesterol [ Time Frame: monitored during 16 weeks ]
  17. Glucose [ Time Frame: monitored during 16 weeks ]
  18. Serum triacylglycerols [ Time Frame: monitored during 16 weeks ]
  19. T-chol/HDL-chol [ Time Frame: monitored during 16 weeks ]
  20. LDL-chol/HDL-chol [ Time Frame: monitored during 16 weeks ]
  21. Systolic blood pressure [ Time Frame: monitored during 16 weeks ]
  22. Diastolic blood pressure [ Time Frame: monitored during 16 weeks ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Women
  • non-smoker
  • non-pregnant
  • non-breastfeeding
  • serum ferritin <40 ng/ml
  • hemoglobin>=11g/dl

Exclusion Criteria:

  • Serum Ferritin >=40 ng/ml
  • Hemoglobin <11g/dl
  • Amenorrhea
  • Menopause
  • Iron deficiency anemia
  • Thalassemia
  • Hemochromatosis
  • Blood donors
  • Chronic gastric diseases
  • Renal diseases
  • Eating disorders
  • Allergy to any component of the study juices
  • Consumption of iron or ascorbic acid supplements within 4 month prior to participating in the study
More Information

Navas-Carretero S, Pérez-Granados AM, Sarriá B, Schoppen S, Vaquero MP. Iron bioavailability from pate enriched with encapsulated ferric pyrophosphate or ferrous gluconate in rats. Food Sci Tech Int 13:159-163, 2007.

Responsible Party: M Pilar Vaquero, Scientific Researcher, National Research Council, Spain
ClinicalTrials.gov Identifier: NCT01135576     History of Changes
Other Study ID Numbers: AGL2006/09519/ALI
First Posted: June 3, 2010    Key Record Dates
Last Update Posted: December 24, 2012
Last Verified: December 2012

Keywords provided by M Pilar Vaquero, National Research Council, Spain:
Ferric pyrophosphate
Fruit juice
Functional food
iron status
iron-deficiency anemia

Additional relevant MeSH terms:
Anemia, Iron-Deficiency
Hematologic Diseases
Anemia, Hypochromic
Iron Metabolism Disorders
Metabolic Diseases
Trace Elements
Growth Substances
Physiological Effects of Drugs